Stockscreener 앱 받기
5.22
4.57%
-0.25
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$18,115.81 in Stock - Defense World
Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$18,115.81 in Stock - MarketBeat
Fennec Pharmaceuticals (TSE:FRX) Hits New 1-Year Low at $7.00 - MarketBeat
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - Kincardine News
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - Prince George Post
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - StockTitan
Fennec Pharmaceuticals director sells shares worth over $13k - Investing.com
Fennec Pharmaceuticals director sells shares worth over $13k By Investing.com - Investing.com UK
Fennec Pharmaceuticals (TSE:FRX) Shares Cross Below Fifty Day Moving Average of $8.25 - MarketBeat
Fennec Pharmaceuticals Inc Forecasted to Post FY2024 Earnings of ($0.21) Per Share (NASDAQ:FENC) - MarketBeat
Research Analysts Set Expectations for Fennec Pharmaceuticals Inc’s FY2024 Earnings (NASDAQ:FENC) - Defense World
Cantor Fitzgerald Weighs in on Fennec Pharmaceuticals Inc.’s FY2024 Earnings (TSE:FRX) - Defense World
(FENC) Trading Advice - Stock Traders Daily
Fennec Pharma stock target cut, holds rating on slow PEDMARK sales - Investing.com
Fennec Pharmaceuticals (NASDAQ:FENC) Price Target Cut to $13.00 by Analysts at HC Wainwright - MarketBeat
Fennec Pharmaceuticals (NASDAQ:FENC) Price Target Cut to $13.00 by Analysts at HC Wainwright - Defense World
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This Year - Yahoo Finance
Craig Hallum Lowers Fennec Pharmaceuticals (NASDAQ:FENC) Price Target to $15.00 - Defense World
Capital One Financial Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc (NASDAQ:FENC) - MarketBeat
Fennec Pharmaceuticals (NASDAQ:FENC) Releases Earnings Results, Misses Expectations By $0.26 EPS - MarketBeat
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are More Bearish Than They Used To Be - Simply Wall St
Vanguard Group Inc. Sells 126,437 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - MarketBeat
FY2027 Earnings Estimate for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Issued By Capital One Financial - Defense World
Fennec Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
FY2027 EPS Estimates for Fennec Pharmaceuticals Inc Reduced by Capital One Financial (NASDAQ:FENC) - MarketBeat
Q3 2024 EPS Estimates for Fennec Pharmaceuticals Inc (NASDAQ:FENC) Lowered by Wedbush - Defense World
Vanguard Group Inc. Sells 126,437 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Brokers Offer Predictions for Fennec Pharmaceuticals Inc’s FY2026 Earnings (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $7.49 - MarketBeat
Investing in Fennec Pharmaceuticals Inc (FENC): What You Must Know - Knox Daily
Fennec Pharmaceuticals (NASDAQ:FENC) Price Target Lowered to $15.00 at Craig Hallum - MarketBeat
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call Transcript - Insider Monkey
Fennec Pharmaceuticals’ (FENC) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Earnings call: Fennec Pharmaceuticals achieved net revenues of $7.3 million - Investing.com India
Q2 2024 Fennec Pharmaceuticals Inc Earnings Call Transcript - GuruFocus.com
Fennec Pharma stock hits 52-week low at $5.38 amid market challenges - Investing.com
Wedbush Reiterates Outperform Rating for Fennec Pharmaceuticals (NASDAQ:FENC) - MarketBeat
Earnings call: Fennec Pharmaceuticals achieved net revenues of $7.3 million - Investing.com
Earnings call: Fennec Pharmaceuticals achieved net revenues of $7.3 million By Investing.com - Investing.com UK
Fennec Pharma stock hits 52-week low at $5.38 amid market challenges - Investing.com Canada
Fennec Pharma stock hits 52-week low at $5.38 amid market challenges - Investing.com Australia
FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2024 - Marketscreener.com
Fennec Pharma stock hits 52-week low at $5.38 amid market challenges - Investing.com UK
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - BioSpace
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - ForexTV.com
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - wallstreet:online
(FENC) Investment Report - Stock Traders Daily
Fennec Pharmaceuticals (FENC) Set to Announce Earnings on Tuesday - Defense World
Fennec Pharmaceuticals (FRX) Set to Announce Quarterly Earnings on Tuesday - Defense World
Canadian Pacific Kansas City Ltd (CP-T) QuotePress Release - The Globe and Mail
Israeli Shekel/Euro (ILSEUR) QuotePress Release - The Globe and Mail
Fennec Pharmaceuticals Inc (NASDAQ:FENC) to Post Q2 2024 Earnings of ($0.17) Per Share, Capital One Financial Forecasts - MarketBeat
Equities Analysts Set Expectations for Fennec Pharmaceuticals Inc.'s Q2 2024 Earnings (TSE:FRX) - MarketBeat
Research Analysts Offer Predictions for Fennec Pharmaceuticals Inc.’s Q2 2024 Earnings (TSE:FRX) - Defense World
Q2 2024 Earnings Estimate for Fennec Pharmaceuticals Inc Issued By Capital One Financial (NASDAQ:FENC) - Defense World
Fennec Pharmaceuticals (FENC) Set to Announce Earnings on Tuesday - MarketBeat
Fennec Pharmaceuticals (FRX) to Release Earnings on Tuesday - MarketBeat
Libyan Dinar/U.S. Dollar (LYDUSD) QuotePress Release - The Globe and Mail
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 - Financial Post
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 - ForexTV.com
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 - StockTitan
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.89 - MarketBeat
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman As CEO - citybiz
Fennec Pharmaceuticals names new CEO to expand PEDMARK reach By Investing.com - Investing.com Australia
Fennec Pharmaceuticals names new CEO to expand PEDMARK reach By Investing.com - Investing.com Canada
Fennec Pharmaceuticals names new CEO to expand PEDMARK reach - Investing.com
1.26%
1.94%
자본화:
|
볼륨(24시간):